• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Blood Cancer . Thromboelastography profiles in critically ill children with multisystem inflammatory syndrome

tetano

Editor, Senior Moderator
Pediatr Blood Cancer


. 2021 Dec 22;e29426.
doi: 10.1002/pbc.29426. Online ahead of print.
Thromboelastography profiles in critically ill children with multisystem inflammatory syndrome


Kavita Morparia[SUP] 1 [/SUP], Philip C Spinella[SUP] 2 [/SUP], Derrick McQueen[SUP] 1 [/SUP], Meena Kalyanaraman[SUP] 1 [/SUP], Maria Bergel[SUP] 1 [/SUP], John Lin[SUP] 2 [/SUP], Shalu Narang[SUP] 3 [/SUP], Arun Saini[SUP] 4 [/SUP]



Affiliations

Abstract

Objectives: To describe critically ill children's coagulation profile with the multisystem inflammatory syndrome (MIS-C) related to coronavirus.
Study design: Single-center, observational study at a tertiary, pediatric intensive care unit (PICU) in children aged 1 month to 18 years.
Measurements and main results: Sixteen children, with a median age of 5.4 years (interquartile range [IQR] 2.1, 11.75), 56% female, admission Pediatric Logistic Organ Dysfunction-2 (PELOD-2) score of 3.5 (IQR 2, 5), and median PICU length of stay 3 days (IQR 1.5, 4), met criteria of MIS-C. All patients received acetylsalicylic acid (80-100 mg/kg) and none received anticoagulation. Sixty-three percent (10/16) of children had out-of-normal range values on thromboelastography (TEG) (44% [7/16] with hypercoagulability and 19% [3/16] with hypocoagulability). Of those with hypercoagulability, 19% (3/16) had rapid clot formation, and 25% (4/16) had increased clot strength. In 69% (11/16) of children, there was impaired fibrinolysis (0% lysis at 30 minutes) on TEG. Seventy-five percent (12/16) of children had out-of-normal range value on standard coagulation assays (37.5% [6/16] with hypocoagulability and 37.5% [6/16] with hypercoagulability). TEG-G (clot strength as measured by TEG) value (ρ -.553, p = .033) and platelet count (ρ -.840, p < .0001) were correlated with admission PELOD-2 score. TEG-G value (ρ -.506, p = .04) and platelet count (ρ -.539, p = .03) were correlated with the duration of intensive care unit stay.
Conclusions: Coagulation abnormalities are frequent in children with MIS-C. TEG parameter and platelet count are correlated with the severity of multiorgan dysfunction and the duration of intensive care stay. Multicenter studies are needed to confirm the clinical implications of these coagulation abnormalities.

Keywords: COVID-19; MIS-C; TEG; anticoagulation; clotting; coagulopathy; coronavirus; multisystem inflammatory syndrome; pediatric; thromboelastography.
 
Back
Top Bottom